Annual Non Current Assets
$195.34 M
-$90.92 M-31.76%
December 31, 2023
Summary
- As of March 4, 2025, LYEL annual long term assets is $195.34 million, with the most recent change of -$90.92 million (-31.76%) on December 31, 2023.
- During the last 3 years, LYEL annual non current assets has fallen by -$95.39 million (-32.81%).
- LYEL annual non current assets is now -61.02% below its all-time high of $501.12 million, reached on December 31, 2021.
Performance
LYEL Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$169.17 M
+$14.85 M+9.62%
September 30, 2024
Summary
- As of March 4, 2025, LYEL quarterly long term assets is $169.17 million, with the most recent change of +$14.85 million (+9.62%) on September 30, 2024.
- Over the past year, LYEL quarterly non current assets has stayed the same.
- LYEL quarterly non current assets is now -70.17% below its all-time high of $567.19 million, reached on September 30, 2021.
Performance
LYEL Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
LYEL Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.8% | 0.0% |
| 3 y3 years | -32.8% | -66.2% |
| 5 y5 years | +69.3% | -57.2% |
LYEL Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.0% | at low | -66.2% | +9.6% |
| 5 y | 5-year | -61.0% | +69.3% | -70.2% | +9.6% |
| alltime | all time | -61.0% | +69.3% | -70.2% | +9.6% |
Lyell Immunopharma Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $169.17 M(+9.6%) |
| Jun 2024 | - | $154.32 M(-3.6%) |
| Mar 2024 | - | $160.06 M(-18.1%) |
| Dec 2023 | $554.69 M(-14.8%) | $195.34 M(-6.1%) |
| Sep 2023 | - | $208.13 M(-9.1%) |
| Jun 2023 | - | $228.94 M(-10.6%) |
| Mar 2023 | - | $256.05 M(-10.6%) |
| Dec 2022 | $651.29 M | $286.27 M(-9.8%) |
| Sep 2022 | - | $317.52 M(-10.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $354.90 M(-20.5%) |
| Mar 2022 | - | $446.40 M(-10.9%) |
| Dec 2021 | $626.29 M(+1.4%) | $501.12 M(-11.6%) |
| Sep 2021 | - | $567.19 M(+43.6%) |
| Jun 2021 | - | $395.03 M(+47.7%) |
| Mar 2021 | - | $267.45 M(-8.0%) |
| Dec 2020 | $617.55 M(+40.3%) | - |
| Dec 2020 | - | $290.73 M |
| Dec 2019 | $440.26 M | - |
FAQ
- What is Lyell Immunopharma annual long term assets?
- What is the all time high annual non current assets for Lyell Immunopharma?
- What is Lyell Immunopharma annual non current assets year-on-year change?
- What is Lyell Immunopharma quarterly long term assets?
- What is the all time high quarterly non current assets for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly non current assets year-on-year change?
What is Lyell Immunopharma annual long term assets?
The current annual non current assets of LYEL is $195.34 M
What is the all time high annual non current assets for Lyell Immunopharma?
Lyell Immunopharma all-time high annual long term assets is $501.12 M
What is Lyell Immunopharma annual non current assets year-on-year change?
Over the past year, LYEL annual long term assets has changed by -$90.92 M (-31.76%)
What is Lyell Immunopharma quarterly long term assets?
The current quarterly non current assets of LYEL is $169.17 M
What is the all time high quarterly non current assets for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly long term assets is $567.19 M
What is Lyell Immunopharma quarterly non current assets year-on-year change?
Over the past year, LYEL quarterly long term assets has changed by $0.00 (0.00%)